Investing Profile
Kanad Das
InvestorVC
Interim CBO SiteOne Therapeutics at SiteOne Therapeutics, Inc.
boehringer-ingelheim-venture....San Francisco, California
Your Intro Paths to Kanad Das
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Kanad is a member of
Stanford University Network
256 CONNECTIONS
Genentech Network
47 CONNECTIONS
Merck Network
36 CONNECTIONS
Boehringer Ingelheim Network
17 CONNECTIONS
Bristol Myers Squibb Network
15 CONNECTIONS
Find Kanad Das on
cbCurrent Investing Position
Investment Range
$3.3M - $17.0M
Sweet Spot
$8.5M
Investments On Record
4
Kanad Das is on these Sector & Stage Rankings
Kanad Das's Investments On Record (2)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Actym Therapeutics, Inc. | Series AOct 2023$26M Series AApr 2020$34M | $60M |
Viron | Series BDec 2021$50M Series AJun 2019$25M | $75M |
Kanad Das's Experience
Interim CBO SiteOne Therapeutics SiteOne Therapeutics, Inc.2024 - Present
Venture Partner Bioluminescence Ventures2024 - 2025
Senior Director Bristol Myers Squibb2023 - 2024
Board Of Directors Libra Therapeutics2021 - 2023
Board of Directors Actym Therapeutics, Inc.2020 - 2023
Board of Directors OncoMyx Therapeutics2019 - 2023
Investment Director, Boehringer Ingelheim Venture Fund Boehringer Ingelheim2018 - 2023
Board of Directors Sentien Biotechnologies, Inc.2021 - 2021
Director, Business Development Merck2015 - 2018
Associate Director, SPARK Partnering and Alliance Management Stanford University2012 - 2015
Advisor SPARK Program2011 - 2012
Consultant Dermira, Inc.2011 - 2012
Senior Scientist KAI Pharmaceuticals2006 - 2010
Post-Doc Genentech2003 - 2006
Founders who looked at Kanad Das' profile also looked at these Scouts & Angels